tiprankstipranks
Trending News
More News >
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Technical Analysis

Compare
335 Followers

Technical Sentiment

Overall Consensus
Neutral
11Bullish
1Neutral
10Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
6Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Keros Therapeutics’s (KROS) Moving Averages Convergence Divergence (MACD) indicator is 0.62, suggesting Keros Therapeutics is a Sell.
Keros Therapeutics’s (KROS) 20-Day exponential moving average is 11.96, while Keros Therapeutics’s (KROS) share price is $14.07, making it a Buy.
Keros Therapeutics’s (KROS) 50-Day exponential moving average is 13.15, while Keros Therapeutics’s (KROS) share price is $14.07, making it a Buy.

Keros Therapeutics (KROS) Pivot Points

Apr 22, 2025, 05:57 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.81
13.12
13.59
13.90
14.37
14.68
15.15
Fibonacci
13.12
13.41
13.60
13.90
14.19
14.38
14.68
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Keros Therapeutics (KROS) Moving Averages

Apr 22, 2025, 05:57 PM
Period
Simple
Exponential
MA5
13.55Buy
13.51Buy
MA10
12.22Buy
12.68Buy
MA20
11.39Buy
11.96Buy
MA50
11.20Buy
13.15Buy
MA100
18.93Sell
19.85Sell
MA200
36.29Sell
32.56Sell
Keros Therapeutics’s (KROS) 10-Day exponential moving average is 12.68, while Keros Therapeutics’s (KROS) share price is $14.07, making it a Buy.
Keros Therapeutics’s (KROS) 100-Day exponential moving average is 19.85, while Keros Therapeutics’s (KROS) share price is $14.07, making it a Sell.
Keros Therapeutics’s (KROS) stock price is $14.07 and Keros Therapeutics’s (KROS) 50-day simple moving average is 11.20, creating a Buy signal.
Keros Therapeutics’s (KROS) stock price is $14.07 and Keros Therapeutics’s (KROS) 100-day simple moving average is 18.93, creating a Sell signal.
Keros Therapeutics’s (KROS) stock price is $14.07 and Keros Therapeutics’s (KROS) 200-day simple moving average is 36.29, creating a Sell signal.

Keros Therapeutics (KROS) Technical Indicators

Apr 22, 2025, 05:57 PM
Name
Value
Implied Action
RSI (14)
73.95
Sell
STOCH (9,6)
96.55
Sell
STOCHRSI (14)
96.55
Sell
MACD (12,26)
0.62
Sell
ADX (14)
26.74
Neutral
Williams %R
-6.67
Sell
CCI (14)
160.13
Sell
ATR (14)
0.76
-
Ultimate Oscillator
74.26
Buy
ROC
40.33
Buy
Keros Therapeutics’s (KROS) Relative Strength Index (RSI) is 73.95, creating a Sell signal.
Keros Therapeutics’s (KROS) Trend Strength Indicator (ADX) is 26.74, creating a Neutral signal.
Keros Therapeutics’s (KROS) Commodity Channel Index (CCI) is 160.13, creating a Sell signal.
Keros Therapeutics’s (KROS) Price Rate of Change (ROC) is 40.33, creating a Buy signal.

FAQ

Is KROS a Buy, Hold, or Sell?
Based on KROS’s technical indicators, KROS is a Hold.
    What is KROS’s RSI (14)?
    KROS’s RSI (14) is 73.95, which suggests KROS is a Sell.
      What is KROS’s MACD?
      KROS’s MACD is 0.62, which suggests KROS is a Sell.
        What is KROS’s 5-day moving average?
        KROS’s 5-day moving average is 13.55, which suggests KROS is a Buy.
          What is KROS’s 20-day moving average?
          KROS 20-day moving average is 11.39, which suggests KROS is a Buy.
            What is KROS’s 50-day moving average?
            KROS’s 50-day moving average is 11.20, which suggests KROS is a Buy.
              What is KROS’s 200-day moving average?
              KROS’s 200-day moving average is 36.29, which suggests KROS is a Sell.
                What is KROS’s Williams % R (14)?
                KROS’s Williams % R (14) is -6.67, which suggests KROS is a Sell.
                  What is KROS’s CCI (14)?
                  KROS’s CCI (14) is 160.13, which suggests KROS is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis